Skip to main content
. 2017 Jan 13;8(8):13832–13845. doi: 10.18632/oncotarget.14640

Figure 3. Metformin stabilizes CEBPD protein through reduced Src activity in Huh7 cells.

Figure 3

(A) Huh7 cells were pretreated with or without Met (5 mM) for 2 h and then treated with cyclohexamide (CHX, 10 μg/ml) to inhibit de novo synthetic proteins. Protein lysates were extracted at the indicated time points, and the remaining proteins were analyzed by Western blotting. (B) Huh7 cells were treated with Met (5 mM) at indicated time points or (C) treated with SKI-606 for 24 h. The experimental cell lysates were harvested for Western blot analyses.